Published in Toxicol Appl Pharmacol on November 15, 2001
3'-Azido-3'-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity. Biochem Pharmacol (2006) 1.25
A review of the toxicity of HIV medications. J Med Toxicol (2014) 1.19
Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. Cardiovasc Toxicol (2004) 1.11
3'-Azido-3'-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria. Biochem Pharmacol (2006) 1.02
Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry. Anal Chem (2010) 1.01
Zidovudine and Lamivudine for HIV Infection. Clin Med Rev Ther (2010) 0.89
Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction. Cardiovasc Toxicol (2008) 0.89
High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers. Antimicrob Agents Chemother (2008) 0.87
The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytes. Br J Pharmacol (2009) 0.79
A computational model of mitochondrial AZT metabolism. Biochem J (2005) 0.77
Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors. Drug Discov Today Technol (2012) 0.75
Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system. Redox Biol (2017) 0.75
Reproductive tract infections and abortion among adolescent girls in rural Nigeria. Lancet (1995) 4.86
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet (1996) 4.07
Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet (2001) 3.49
Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey. Crit Care Med (1991) 3.29
Antibiotic resistance found in wild rodents. Nature (1999) 3.20
Mortality in severe meningococcal disease. Arch Dis Child (2001) 3.03
Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2003) 2.56
Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Antimicrob Agents Chemother (2001) 2.39
Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol (1999) 2.33
Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J (2000) 2.32
Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet (2000) 2.28
Vulvovaginitis: causes and management. Arch Dis Child (1992) 2.28
Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharmacol (1997) 2.26
Who spots the spots? Diagnosis and treatment of early meningococcal disease in children. BMJ (1996) 2.20
The pharmacokinetics of combination therapy with nelfinavir plus nevirapine. AIDS (1998) 2.16
Human cryptosporidiosis: a possible case of hospital cross infection. Br Med J (Clin Res Ed) (1983) 2.02
Updating the nurse's bedside manner. Image J Nurs Sch (1993) 2.02
Antibiotic resistance: an increasing problem?. It always has been, but there are things we can do. BMJ (1998) 2.00
An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay. Contraception (1979) 1.97
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Proc Natl Acad Sci U S A (1981) 1.90
Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health (1999) 1.90
Human herpesviruses in the cornea. Br J Ophthalmol (2000) 1.90
Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood (1998) 1.89
Hantaviruses. J Med Microbiol (2000) 1.86
Northwick Park Infection Consultation Service. Part II. Contribution of the service to patient management: an analysis of results between September 1987 and July 1990. J Infect (1991) 1.76
The prevalence of enteric pathogens in diarrhoeic thoroughbred foals in Britain and Ireland. Equine Vet J (1991) 1.76
Genotype analysis of Escherichia coli strains isolated from children and chickens living in close contact. Appl Environ Microbiol (1999) 1.73
The development and performance of a simple, sensitive method for the detection of Cryptosporidium oocysts in faeces. J Hyg (Lond) (1984) 1.73
Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ (1998) 1.72
Severe hypophosphatemia in children with kwashiorkor is associated with increased mortality. J Pediatr (1998) 1.70
Isolation from Klebsiella and characterization of two rcs genes that activate colanic acid capsular biosynthesis in Escherichia coli. J Gen Microbiol (1987) 1.70
Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child (2002) 1.69
Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol (2001) 1.68
Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet (2001) 1.67
Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect (2008) 1.66
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. Antimicrob Agents Chemother (1997) 1.66
Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child (1991) 1.65
Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS (1997) 1.65
Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child (1995) 1.65
Clinical pharmacokinetics of oral contraceptive steroids. Clin Pharmacokinet (1983) 1.64
Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child (2002) 1.64
Multi-drug resistant typhoid: a global problem. J Med Microbiol (1996) 1.64
The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol (1987) 1.63
Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis (1996) 1.63
Particles with properties of retroviruses in monocytes from patients with breast cancer. Lancet (1988) 1.62
Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax (2004) 1.62
Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer (1998) 1.61
Bovine digital dermatitis and severe virulent ovine foot rot: a common spirochaetal pathogenesis. Vet J (2005) 1.59
Tuberculous pericarditis confirmed by DNA amplification. Lancet (1991) 1.54
Procalcitonin as a marker of sepsis. Int J Antimicrob Agents (2002) 1.52
Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J Clin Microbiol (2006) 1.51
Prophylactic treatment of anthrax with antibiotics. BMJ (2001) 1.51
Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in seropositive and seronegative rheumatic disease. Clin Exp Immunol (1984) 1.50
Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax (1998) 1.50
Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar typhi from Asia. J Clin Microbiol (2000) 1.49
Pulsed-field gel electrophoresis of degradation-sensitive DNAs from Clostridium difficile PCR ribotype 1 strains. J Clin Microbiol (2000) 1.48
Nitric oxide production in meningococcal disease is directly related to disease severity. Crit Care Med (1999) 1.47
Selective decontamination of the digestive tract (SDD) in intensive care patients: a critical evaluation of the clinical, bacteriological and epidemiological benefits. J Hosp Infect (1991) 1.46
Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect (2005) 1.46
Is Mycoplasma hominis a vaginal pathogen? Sex Transm Infect (2001) 1.46
Severe meningococcal disease in childhood. Br J Anaesth (2003) 1.45
Hypocalcaemia in severe meningococcal infections. Arch Dis Child (2000) 1.45
The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tuber Lung Dis (1995) 1.45
Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J (1992) 1.44
Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. AIDS (1999) 1.44
Gastro-enteritis due to Cryptosporidium: a prospective survey in a children's hospital. J Infect (1984) 1.43
Sputum induction for the diagnosis of tuberculosis. Arch Dis Child (1996) 1.43
The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes. Br J Clin Pharmacol (1991) 1.42
Quantitative trait loci (QTLs) associated with resistance/susceptibility to infectious pancreatic necrosis virus (IPNV) in rainbow trout (Oncorhynchus mykiss). Mol Genet Genomics (2001) 1.42
Frequency and spatial distribution of environmental Campylobacter spp. Appl Environ Microbiol (2004) 1.42
Hepatitis G virus infection in drug users in Liverpool. J Infect (1998) 1.41
The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. AIDS (1996) 1.41
The interaction of antibiotics with synthetic steroids in the rat [proceedings]. Br J Pharmacol (1978) 1.40
Plasma fibronectin levels in meningococcal disease. Eur J Pediatr (1997) 1.40
Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann Trop Paediatr (2001) 1.39
Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax (2002) 1.39
Ecdysone agonist inducible transcription in transgenic tobacco plants. Plant J (1999) 1.38
Resistance to cephalosporins among gentamicin-resistant klebsiellae. J Antimicrob Chemother (1982) 1.38
Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population. HIV Med (2009) 1.38
Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect (1998) 1.37
Lamivudine (3TC) phosphorylation and drug interactions in vitro. Biochem Pharmacol (1997) 1.37
Presence of type III secretion genes in Burkholderia pseudomallei correlates with Ara(-) phenotypes. J Clin Microbiol (2000) 1.36
Interindividual variation and drug interactions with hormonal steroid contraceptives. Drugs (1981) 1.36
The incidence of cryptosporidiosis: a two-year prospective survey in a children's hospital. J Hyg (Lond) (1986) 1.36
Variation in serum C-reactive protein across the clinical spectrum of meningococcal disease. Acta Paediatr (1993) 1.36
Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child (2003) 1.36
The intracellular pharmacology of antiretroviral protease inhibitors. J Antimicrob Chemother (2004) 1.35
P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance? AIDS (2001) 1.35
Reduced transfer of tetanus antibodies with placental malaria. Lancet (1994) 1.35
Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut (1995) 1.34
Fluoroquinolones: place in ocular therapy. Drugs (2001) 1.34
Intermittent and persistent shedding of Escherichia coli O157 in cohorts of naturally infected calves. J Appl Microbiol (2004) 1.33
Evidence for the presence in Burkholderia pseudomallei of a type III secretion system-associated gene cluster. J Med Microbiol (1999) 1.31
The changing presentations of meningococcal disease. Eur J Pediatr (1995) 1.31
Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Arch Dis Child (2000) 1.30